AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
160 hedge funds and large institutions have $1.76B invested in Aerie Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 65 increasing their positions, 56 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
40% less capital invested
Capital invested by funds: $2.96B → $1.76B (-$1.19B)
46% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 35
Holders
160
Holding in Top 10
8
Calls
$12.2M
Puts
$7.3M
Top Buyers
| 1 | +$30.2M | |
| 2 | +$26.9M | |
| 3 | +$20.3M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$17.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$16.2M |
Top Sellers
| 1 | -$63.5M | |
| 2 | -$22.8M | |
| 3 | -$17.2M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$15.9M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$13.2M |